Your browser doesn't support javascript.
loading
A randomized, placebo-controlled trial of latrepirdine in Huntington disease.
Kieburtz, Karl; McDermott, Michael P; Voss, Tiffini S; Corey-Bloom, Jody; Deuel, Lisa M; Dorsey, E Ray; Factor, Stewart; Geschwind, Michael D; Hodgeman, Karen; Kayson, Elise; Noonberg, Sarah; Pourfar, Michael; Rabinowitz, Karen; Ravina, Bernard; Sanchez-Ramos, Juan; Seely, Lynn; Walker, Francis; Feigin, Andrew.
Affiliation
  • Kieburtz K; Department of Neurology, University of Virginia, Charlottesville, VA 22908, USA.
Arch Neurol ; 67(2): 154-60, 2010 Feb.
Article in En | MEDLINE | ID: mdl-20142523
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antipsychotic Agents / Huntington Disease / Indoles Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Arch Neurol Year: 2010 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antipsychotic Agents / Huntington Disease / Indoles Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Arch Neurol Year: 2010 Document type: Article Affiliation country: United States Country of publication: United States